Intelligent Bio Solutions (INBS) Change in Accured Expenses (2022 - 2024)
Intelligent Bio Solutions has reported Change in Accured Expenses over the past 3 years, most recently at -$219399.0 for Q1 2024.
- Quarterly results put Change in Accured Expenses at -$219399.0 for Q1 2024, down 17750.76% from a year ago — trailing twelve months through Mar 2024 was -$214345.0 (down 1746.21% YoY), and the annual figure for FY2023 was -$25724.0, down 189.15%.
- Change in Accured Expenses for Q1 2024 was -$219399.0 at Intelligent Bio Solutions, down from $2261.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for INBS hit a ceiling of $14077.0 in Q2 2022 and a floor of -$219399.0 in Q1 2024.
- Median Change in Accured Expenses over the past 3 years was $1752.0 (2023), compared with a mean of -$28244.4.
- Biggest five-year swings in Change in Accured Expenses: soared 109.49% in 2023 and later plummeted 17750.76% in 2024.
- Intelligent Bio Solutions' Change in Accured Expenses stood at $2905.0 in 2022, then decreased by 22.17% to $2261.0 in 2023, then plummeted by 9803.63% to -$219399.0 in 2024.
- The last three reported values for Change in Accured Expenses were -$219399.0 (Q1 2024), $2261.0 (Q4 2023), and $2830.0 (Q3 2023) per Business Quant data.